News provided by Scripta Insights May 20, 2025, 08:00 ET New member app feature delivers trusted, clinician-backed guidance as millions face GLP-1 access setbacks after CVS Caremark drops Zepbound and WeightWatchers files for bankruptcy BOSTON, May 20, 2025 /PRNewswire/ -- Scripta Insights , the doctor-driven, AI-powered pharmacy navigation company that guides self-insured employers, health plans and their members to prescription savings, announces today its GLP-1 Navigator , a new resource in the Scripta member app that gives patients up-to-date, trusted information about GLP-1 medications in a centralized guide
Mechanism of action of potential anticancer drugs
Long Term GLP-1 Use: Maintenance and Offboarding The conversation around GLP-1s is slowly shifting from short term weight loss to long term strategies for maintenance and offboarding
Before administration, the medication may be removed from refrigeration and allowed to reach room temperature, which can help reduce injection site discomfort
Acute ischemic stroke may upregulate GLP-1 receptors, supporting a biologic rationale for post-stroke administration, although definitive acute-treatment efficacy remains unproven
Sustainable Results Our holistic approach ensures that your weight loss is not only noticeable but also lasting and safe